Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population.

Diana Brixner | Manish Mittal | David T Rubin | Philip Mease | Harry H Liu | Matthew Davis | Arijit Ganguli | A Mark Fendrick
Patient preference and adherence | 2019

Nonadherence to indicated therapy reduces treatment effectiveness and may increase cost of care. HUMIRA Complete, a Patient Support Program (PSP), aims to reduce nonadherence in patients prescribed adalimumab (ADA). The objective of this study was to assess the relationship between participation in the PSP and prescription abandonment rates among ADA-treated patients.

Pubmed ID: 31571837

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


AbbVie (tool)

RRID:SCR_010484

A research-based biopharmaceutical company that develops advanced therapies to address global health problems.

View all literature mentions